 |
|
|
| |
Changes in Renal Function After Switching from Emtricitabine/Tenofovir Disoproxil Fumarate to Emtricitabine/Tenofovir Alafenamide Fumarate for HIV Pre-exposure Prophylaxis (PrEP): A Real-World Study
|
| |
| |
IDWeek 2024; October 16-19, 2024; Los Angeles, CA, USA
Kaori L. Ito, Xiwen Huang, Seojin Park, Li Tao, and Joshua Gruber
Gilead Sciences, Inc., Foster City, CA, US
|
| |
|
|
|
|
|
